Insmed | INSM - Capital Y Las Reservas

Precio De Mercado
154.81
Cambio Diario
-4.78 -3.00%
Mensual
11.05%
Anual
125.77%
Q2 Expectativa
150.58




Capital Y Las Reservas Cambio Fecha
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Novartis USD 46.13B 1.8B 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12